NYSE Content Advisory: Pre-Market update + Wall Street watches the Middle East


Werte in diesem Artikel

NEW YORK, June 24, 2025 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. 

Kristen Scholer delivers the pre-market update on June 24th

  • Equities are rising Tuesday morning as traders closely monitor the latest developments in the Middle East. On Monday, the major averages rose by close to 1% amid the region's ongoing conflict.
  • At approximately 6 PM ET yesterday evening, President Donald Trump announced on Truth Social that a ceasefire agreement has been reached between Israel and Iran. However, Israel and Iran launched more missiles after the start of the ceasefire.
  • Investors will get a read on consumer confidence this morning. The index showed a mild rebound in May following the pause on some tariffs between the U.S. and China.

Opening Bell
Edwards Lifesciences (NYSE: EW) celebrates its 25th anniversary of listing

Closing Bell
Tweedy, Browne celebrates the launch of Tweedy, Browne Insider + Value ETF (NYSE Arca: COPY)

Click here to download the NYSE TV App

NYSE Logo (PRNewsfoto/New York Stock Exchange)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-advisory-pre-market-update--wall-street-watches-the-middle-east-302489673.html

SOURCE New York Stock Exchange

Aktuelle Edwards Lifesciences Aktie News

Werbung

Edwards Lifesciences Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Edwards Lifesciences nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
18.03.19 Edwards Lifesciences Buy Canaccord Adams
03.01.19 Edwards Lifesciences Hold Deutsche Bank AG
16.10.18 Edwards Lifesciences Underweight Barclays Capital
02.02.18 Edwards Lifesciences Buy Canaccord Adams
04.01.18 Edwards Lifesciences Overweight Barclays Capital